Clariant Valuation

Is 0QJS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QJS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QJS (CHF10.7) is trading above our estimate of fair value (CHF10.23)

Significantly Below Fair Value: 0QJS is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QJS?

Key metric: As 0QJS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QJS. This is calculated by dividing 0QJS's market cap by their current earnings.
What is 0QJS's PE Ratio?
PE Ratio29.5x
EarningsCHF 118.00m
Market CapCHF 3.48b

Price to Earnings Ratio vs Peers

How does 0QJS's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QJS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20x
JMAT Johnson Matthey
4.3x-21.3%UK£2.3b
CRDA Croda International
29.5x15.2%UK£4.8b
VCT Victrex
24.6x37.8%UK£756.5m
TET Treatt
21.5x15.3%UK£242.9m
0QJS Clariant
29.5x29.4%CHF 3.5b

Price-To-Earnings vs Peers: 0QJS is expensive based on its Price-To-Earnings Ratio (29.5x) compared to the peer average (20x).


Price to Earnings Ratio vs Industry

How does 0QJS's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0QJS 29.5xIndustry Avg. 17.3xNo. of Companies12PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QJS is expensive based on its Price-To-Earnings Ratio (29.5x) compared to the European Chemicals industry average (17.3x).


Price to Earnings Ratio vs Fair Ratio

What is 0QJS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QJS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.5x
Fair PE Ratio21.9x

Price-To-Earnings vs Fair Ratio: 0QJS is expensive based on its Price-To-Earnings Ratio (29.5x) compared to the estimated Fair Price-To-Earnings Ratio (21.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QJS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 10.70
CHF 15.15
+41.6%
10.1%CHF 18.00CHF 12.50n/a17
Nov ’25CHF 12.13
CHF 15.16
+25.0%
10.1%CHF 18.00CHF 12.50n/a17
Oct ’25CHF 12.93
CHF 15.81
+22.3%
11.5%CHF 20.00CHF 12.50n/a17
Sep ’25CHF 13.42
CHF 16.01
+19.3%
11.3%CHF 20.00CHF 12.50n/a17
Aug ’25CHF 13.07
CHF 16.04
+22.7%
11.4%CHF 20.00CHF 12.00n/a17
Jul ’25CHF 14.62
CHF 15.66
+7.1%
12.7%CHF 20.00CHF 12.00n/a15
Jun ’25CHF 14.26
CHF 15.31
+7.4%
13.9%CHF 20.00CHF 12.00n/a15
May ’25CHF 13.76
CHF 15.08
+9.6%
13.3%CHF 20.00CHF 12.00n/a15
Apr ’25CHF 12.19
CHF 14.14
+16.0%
15.0%CHF 20.00CHF 11.50n/a15
Mar ’25CHF 11.29
CHF 14.54
+28.8%
14.5%CHF 20.00CHF 11.50n/a14
Feb ’25CHF 11.04
CHF 14.76
+33.7%
14.1%CHF 20.00CHF 11.50n/a14
Jan ’25CHF 12.42
CHF 15.47
+24.6%
11.3%CHF 20.00CHF 13.00n/a14
Dec ’24CHF 13.00
CHF 16.11
+23.9%
13.9%CHF 22.00CHF 13.90n/a15
Nov ’24CHF 12.96
CHF 16.11
+24.3%
13.9%CHF 22.00CHF 13.90CHF 12.1315
Oct ’24CHF 14.50
CHF 16.27
+12.2%
13.2%CHF 22.00CHF 14.00CHF 12.9315
Sep ’24CHF 14.87
CHF 16.44
+10.6%
14.6%CHF 22.00CHF 14.00CHF 13.4216
Aug ’24CHF 14.24
CHF 16.44
+15.5%
14.3%CHF 22.00CHF 14.00CHF 13.0716
Jul ’24CHF 12.90
CHF 17.97
+39.3%
14.4%CHF 24.00CHF 15.00CHF 14.6217
Jun ’24CHF 13.26
CHF 18.20
+37.3%
13.4%CHF 24.00CHF 15.00CHF 14.2617
May ’24CHF 14.80
CHF 18.57
+25.5%
12.0%CHF 24.00CHF 16.00CHF 13.7617
Apr ’24CHF 15.11
CHF 18.73
+23.9%
11.3%CHF 24.00CHF 16.00CHF 12.1917
Mar ’24CHF 15.42
CHF 18.88
+22.4%
11.1%CHF 24.00CHF 16.00CHF 11.2917
Feb ’24CHF 15.87
CHF 18.96
+19.5%
10.7%CHF 24.00CHF 16.00CHF 11.0417
Jan ’24CHF 14.65
CHF 19.08
+30.2%
10.5%CHF 24.00CHF 16.00CHF 12.4217
Dec ’23CHF 15.33
CHF 19.17
+25.0%
10.4%CHF 24.00CHF 16.00CHF 13.0017
Nov ’23CHF 15.91
CHF 19.32
+21.4%
10.3%CHF 24.00CHF 16.00CHF 12.9617

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies